IL160380A0 - Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridines - Google Patents

Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridines

Info

Publication number
IL160380A0
IL160380A0 IL16038002A IL16038002A IL160380A0 IL 160380 A0 IL160380 A0 IL 160380A0 IL 16038002 A IL16038002 A IL 16038002A IL 16038002 A IL16038002 A IL 16038002A IL 160380 A0 IL160380 A0 IL 160380A0
Authority
IL
Israel
Prior art keywords
triazolo
pyrazolo
pyridines
tricyclic
dihydro
Prior art date
Application number
IL16038002A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL160380A0 publication Critical patent/IL160380A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M13/00Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL16038002A 2001-09-12 2002-09-02 Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridines IL160380A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0122031.8A GB0122031D0 (en) 2001-09-12 2001-09-12 Use of pde4 inhibitors in a dry powder inhaler
PCT/IB2002/003599 WO2003022275A1 (en) 2001-09-12 2002-09-02 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines

Publications (1)

Publication Number Publication Date
IL160380A0 true IL160380A0 (en) 2004-07-25

Family

ID=9921954

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16038002A IL160380A0 (en) 2001-09-12 2002-09-02 Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridines

Country Status (34)

Country Link
US (3) US20030064034A1 (is)
EP (1) EP1427414A1 (is)
JP (1) JP2005505560A (is)
KR (1) KR20040036940A (is)
CN (1) CN1553801A (is)
AP (2) AP2002002623A0 (is)
AR (2) AR036473A1 (is)
BG (1) BG108569A (is)
BR (1) BR0212449A (is)
CA (1) CA2457717A1 (is)
CZ (1) CZ2004310A3 (is)
EA (1) EA006742B1 (is)
EC (1) ECSP045018A (is)
EE (1) EE200400078A (is)
GB (1) GB0122031D0 (is)
HN (2) HN2002000253A (is)
HR (1) HRP20040162A2 (is)
HU (1) HUP0401890A3 (is)
IL (1) IL160380A0 (is)
IS (1) IS7151A (is)
MA (1) MA27062A1 (is)
MX (1) MXPA04002354A (is)
NO (1) NO20041011L (is)
NZ (1) NZ530929A (is)
OA (1) OA12660A (is)
PA (2) PA8554701A1 (is)
PE (2) PE20030443A1 (is)
PL (1) PL368736A1 (is)
SK (1) SK1272004A3 (is)
SV (2) SV2004001227A (is)
TN (1) TNSN04040A1 (is)
TW (1) TW200602054A (is)
WO (2) WO2003022275A1 (is)
ZA (1) ZA200401002B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
AU2003302274A1 (en) * 2002-12-31 2004-07-29 Novartis Ag Aerosolizable pharmaceutical formulation for fungal infection therapy
GB0315889D0 (en) * 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
US20060009435A1 (en) * 2004-06-23 2006-01-12 Joseph Kaspi Synthesis and powder preparation of fluticasone propionate
AU2006297037A1 (en) * 2005-09-28 2007-04-05 Merck Frosst Canada Ltd Aerosol powder formulation comprising sieved lactose
GB0801876D0 (en) * 2008-02-01 2008-03-12 Vectura Group Plc Suspension formulations
TR200909788A2 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
PE20151332A1 (es) 2013-02-19 2015-09-20 Pfizer Compuestos de azabencimidazol
KR20150076005A (ko) 2013-12-26 2015-07-06 삼성디스플레이 주식회사 액정 표시 장치
JP6713982B2 (ja) 2014-07-24 2020-06-24 ファイザー・インク ピラゾロピリミジン化合物
KR102061952B1 (ko) 2014-08-06 2020-01-02 화이자 인코포레이티드 이미다조피리다진 화합물
PL3494962T3 (pl) * 2014-09-15 2021-12-06 Verona Pharma Plc Ciekła wziewna kompozycja farmaceutyczna zawierająca RPL554

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004974A (en) * 1995-06-06 1999-12-21 Pfizer Inc Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren

Also Published As

Publication number Publication date
TNSN04040A1 (fr) 2006-06-01
WO2003022279A1 (en) 2003-03-20
PE20030443A1 (es) 2003-05-17
KR20040036940A (ko) 2004-05-03
ZA200401002B (en) 2005-02-07
OA12660A (en) 2006-06-19
EP1427414A1 (en) 2004-06-16
HRP20040162A2 (en) 2004-08-31
MXPA04002354A (es) 2004-06-29
PA8554701A1 (es) 2003-09-17
EA200400301A1 (ru) 2004-06-24
PL368736A1 (en) 2005-04-04
EE200400078A (et) 2004-06-15
NO20041011L (no) 2004-03-10
AR036474A1 (es) 2004-09-08
HN2002000253A (es) 2003-04-07
BG108569A (bg) 2005-02-28
BR0212449A (pt) 2004-08-17
SV2004001226A (es) 2004-02-24
JP2005505560A (ja) 2005-02-24
CN1553801A (zh) 2004-12-08
HN2002000254A (es) 2003-04-07
NZ530929A (en) 2006-08-31
HUP0401890A2 (hu) 2004-12-28
CA2457717A1 (en) 2003-03-20
SK1272004A3 (sk) 2005-03-04
ECSP045018A (es) 2004-04-28
HUP0401890A3 (en) 2008-03-28
PE20030509A1 (es) 2003-06-23
US20030064034A1 (en) 2003-04-03
MA27062A1 (fr) 2004-12-20
GB0122031D0 (en) 2001-10-31
EA006742B1 (ru) 2006-04-28
AP2002002624A0 (en) 2002-09-30
US20030064031A1 (en) 2003-04-03
US20050232871A1 (en) 2005-10-20
SV2004001227A (es) 2004-02-24
AR036473A1 (es) 2004-09-08
IS7151A (is) 2004-02-13
AP2002002623A0 (en) 2002-09-30
PA8554601A1 (es) 2003-09-17
CZ2004310A3 (cs) 2005-02-16
TW200602054A (en) 2006-01-16
WO2003022275A1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
EP1409619A4 (en) COMPOSITE STRUCTURAL ELEMENTS
PL368370A1 (en) Glyphosate composition
ZA200604960B (en) Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-A]pyrimidin-6-onederivatives
SI1608654T1 (sl) 8-subst.-6,7,8,9-tetrahidropirimido(1,2-a)pirimidin-4-onski derivati
HK1090374A1 (en) 6-Ä(substituted)phenylÜ triazolopyrimidines as anticancer agents
EP1465988A4 (en) Myo-inositol oxygenase
PL1608653T3 (pl) Podstawione pochodne 8-perfluoroalkilo-6,7,8,9-tetrahydropirymido(1,2-a)pirymidyn-4-onu
IL160380A0 (en) Inhalation compositions comprising tricyclic 5,6-dihydro-9h- pyrazolo (3,4,-c)-1,2,4-triazolo (4,3-alpha) pyridines
GB0109754D0 (en) Floor treatment compositions
HUP0500330A3 (en) Heterocondensated tricyclic imidazopyridines, their use and pharmaceutical compositions containing them
HK1061026A1 (en) 3,7-Diazabicyclo 3.3.1Ü formulations as antiarhythmic compounds
MXPA03008965A (es) Uso de compuestos de imidazo [1,2-a]-piridinas sustituidas como medicamentos.
PL366919A1 (en) Aromatizing agent
MXPA03008894A (es) Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos.
SG94836A1 (en) Modular structure
AU2002334256A1 (en) Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines and a tiotropium salt
PL354570A1 (en) Modular seat
GB0118950D0 (en) Multi-purpose inhaler
GB2379596B (en) Safety cutlery
HU2242U (en) Multi-purpose playground
GB0116752D0 (en) Leukocyte preparation
CA93107S (en) Vehicle footrest
IL141674A0 (en) Safe cracker game
GB9914783D0 (en) Millennium multi-purpose steps
TW522809U (en) Improvement of multi-purpose simple-structured sitting board